DR. BRETT T BRINKER MD NPI 1750347290

NPI Information

  • NPI: 1750347290
  • Provider Name: DR. BRETT T BRINKER, MD
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 145 MICHIGAN ST NE STE 3100
    GRAND RAPIDS, MI
    ZIP 49503
  • Phone: (616) 954-9800

Map and Directions

Get Directions

NPI Details

DR. Brett T Brinker, MD is a hematology and oncology internal medicine in Grand Rapids, MI with 25 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Brett T Brinker, MD NPI is 1750347290. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: EMORY UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:2000

The provider's business location address is:

145 MICHIGAN ST NE STE 3100
GRAND RAPIDS, MI
ZIP 49503-563
Phone: (616) 954-9800

The NPI 1750347290 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, azacitidine, 1 mg (HCPCS:J9025)
  • Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, rituximab-arrx, biosimilar, (riabni), 10 mg (HCPCS:Q5123)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Measurement of immunoglobulin light chains (HCPCS:83521)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Injection, pegfilgrastim-apgf, biosimilar, (nyvepria), 0.5 mg (HCPCS:Q5122)
  • Protein measurement, serum (HCPCS:84165)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Administration of chemotherapy into vein using push technique (HCPCS:96409)
  • Uric acid level, blood (HCPCS:84550)
  • Blood test, clotting time (HCPCS:85610)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Vitamin d-3 level (HCPCS:82306)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Reticulated (young) platelet measurement (HCPCS:85055)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Magnesium level (HCPCS:83735)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Phosphate level (HCPCS:84100)
  • Unclassified drugs (HCPCS:J3490)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Folic acid level, serum (HCPCS:82746)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Administration of prolonged chemotherapy into vein (HCPCS:96416)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Iron level (HCPCS:83540)
  • Transferrin (iron binding protein) level (HCPCS:84466)
  • Detection test by immunoassay technique for hepatitis b surface antigen (HCPCS:87340)
  • Hepatitis b core antibody measurement (HCPCS:86704)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Hepatitis b surface antibody measurement (HCPCS:86706)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
  • Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody (HCPCS:86769)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
  • Hospital discharge day management, more than 30 minutes (HCPCS:99239)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)

The enumeration date for this NPI number is 4/25/2006 and was last updated on 3/13/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology4301087238MICHIGANYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.